Clinical Trial Update: Gulf War Illness Inflammation Reduction Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating inflammation reduction in Gulf War Illness has completed, with results posted in December 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Fatigue
• Inflammation
• Pain

Snippet

Sponsor: Minneapolis Veterans Affairs Medical Center | Conditions: Chronic Inflammation, Chronic Pain | Phase 2 | Status: COMPLETED | Results posted: 2023-12-06